APAC Prostate Cancer Market, Market Segmented, by Diagnostic Techniques (Digital Rectal Exam (DRE), Prostate-Specific Antigen Test (PSA), by Surgery (Radial Prostatectomy, Orchidectomy, Trans Urethral Resection (TUR)), By Radiation Therapy (External Beam Radiation Therapy, Brachytherapy), and by Chemotherapy (Docetaxel, Etoposide, Vinblastine, Carboplatin, Vinorelbine)- Growth, Trends and Forecast, 2019-2028
- Published Date: 2022-12-26
- Report ID: 138348
- Pages: 200
-
Format:
Report Overview
The APAC Prostate Cancer Market, market size stood at around USD $10.36 billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period
Prostate cancer is a common term used for the diseased situations in which abnormal cells grow and infect in an uncontrolled manner in the prostate. New product inventions, partnership agreements, collaborations, and acquisitions are some of the key strategies adopted by the players to get a large market share in the forecast period
Market Drivers
Advancement in technology, personalized medicine, cost-effective treatment procedures are a few other factors expected to provide a boost to the Asia-Pacific prostate cancer market. Rising incidence of prostate cancers and the availability of various treatment modalities are also fueling market growth. However, limited commercially availability drugs and treatments for this cancer is the challenge restraining the growth of the prostate cancer market
1. APAC Prostate Cancer Market Overview
A. Market Size
2. APAC Prostate Cancer Growth Drivers and Restraints
A. Advancement in technology, personalized medicine, cost-effective treatment procedures
B. Rising incidence of prostate cancers and the availability of various treatment modalities
C. Limited commercially availability drugs and treatments for this cancer
3. APAC Prostate Cancer Market Segmentation
A. By Diagnostic Techniques
I. Digital Rectal Exam (DRE)
II. Prostate-Specific Antigen Test (PSA)
B. By Surgery
I. Radial Prostatectomy
II. Orchidectomy
III. Trans Urethral Resection (TUR)
C. By Radiation Therapy
I. External Beam Radiation Therapy
II. Brachytherapy
D. By Chemotherapy
I. Docetaxel
II. Etoposide
III. Vinblastine
IV. Carboplatin
V. Vinorelbine
4. Prostate Cancer Market Share
A. Market Analysis, Insights and Forecast by Revenue
5. Competitive Landscape
A. Major Players
B. Products in Pipeline
6. Key Company Profiles..
A. Sanofi S.A, Company overview, Product & Services, Strategies & Financials
B. Pfizer, Inc., Company overview, Product & Services, Strategies & Financials
C. F. Hoffmann-La Roche, Company overview, Product & Services, Strategies & Financials
7. Healthcare Policies and Regulatory Landscape.
A. Policy Changes and Reimbursement Scenario
8. Factors Driving Market Growth
A. Key Industry Developments
B. Mergers and Acquisitions
9. Potential Growth Opportunities
A. Market Opportunities
B. Future Trends
10. Conclusion
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
